Literature DB >> 9510031

Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer.

I Dussault1, D Fawcett, A Matthyssen, J A Bader, V Giguère.   

Abstract

It has recently been shown that the neurological mutant mouse staggerer (sg) harbors a deletion within the Rora gene that encodes the orphan nuclear receptor ROR alpha. This deletion removes an exon encoding part of the ligand binding domain of the putative receptor, generating an ROR alpha truncated protein (ROR alpha(sg)). It is unknown whether sg acts as a null or highly hypomorphic allele. To address this question, we have generated a null mutation of Rora by targeted disruption of its DNA binding domain in ES cells. The Rora-/- mice are viable but display tremor, body imbalance, small size and die between 3-4 weeks, similar to the sg mouse. Histological examination of the cerebellum of Rora-/- and sg mice showed similar defects, including small size and fewer ectopically localized Purkinje cells. Northern blot analysis of cerebellar RNA showed that ROR alpha transcripts are still expressed in the Rora-/- and sg mutants, although with altered mobilities. However, the cerebellum of the Rora-/- mutant does not express the ROR alpha protein. Attempts to complement the defect of the Rora-/- with sg failed, demonstrating conclusively that the sg defects are caused by the absence of functional ROR alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510031     DOI: 10.1016/s0925-4773(97)00187-1

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  69 in total

1.  RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways.

Authors:  David A Gold; Sung Hee Baek; Nicholas J Schork; David W Rose; DeLaine D Larsen; Benjamin D Sachs; Michael G Rosenfeld; Bruce A Hamilton
Journal:  Neuron       Date:  2003-12-18       Impact factor: 17.173

2.  Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.

Authors:  Anna N Moraitis; Vincent Giguère; Catherine C Thompson
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

4.  Phenotypic and genetic analysis of the cerebellar mutant tmgc26, a new ENU-induced ROR-alpha allele.

Authors:  Douglas J Swanson; Ekaterina Y Steshina; Paul Wakenight; Kimberly A Aldinger; Dan Goldowitz; Kathleen J Millen; Victor V Chizhikov
Journal:  Eur J Neurosci       Date:  2010-08-16       Impact factor: 3.386

Review 5.  Nuclear receptor coregulators are new players in nervous system development and function.

Authors:  Eijun Nishihara; Bert W O'Malley; Jianming Xu
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

6.  Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deficient mice impairs the functionality of the forebrain clock and affects nociception.

Authors:  Marei Warnecke; Henrik Oster; Jean-Pierre Revelli; Gonzalo Alvarez-Bolado; Gregor Eichele
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

7.  LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum.

Authors:  Yangu Zhao; Kin-Ming Kwan; Christina M Mailloux; Woon-Kyu Lee; Alexander Grinberg; Wolfgang Wurst; Richard R Behringer; Heiner Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

Review 8.  Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Immunology       Date:  2009-03       Impact factor: 7.397

Review 9.  An overview of nuclear receptor coregulators involved in cerebellar development.

Authors:  Eijun Nishihara
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 10.  Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Authors:  Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.